BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND FBXO11, MGC44383, 80204, ENSG00000138081, Q86XK2, VIT1, UG063H01, PRMT9, FLJ12673, FBX11
4 results:

  • 1. Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-box
    Zhang H; Xia P; Yang Z; Liu J; Zhu Y; Huang Z; Zhang Z; Yuan Y
    Clin Transl Med; 2023 Oct; 13(10):e1443. PubMed ID: 37837399
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Ultrasound-targeted microbubble destruction-mediated silencing of fbxo11 suppresses development of pancreatic cancer.
    Xue J; Chen S; Ge D; Yuan X
    Hum Cell; 2022 Jul; 35(4):1174-1191. PubMed ID: 35437704
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The tumor suppressive miR-26a regulation of fbxo11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.
    Ma Y; Deng F; Li P; Chen G; Tao Y; Wang H
    Biomed Pharmacother; 2018 May; 101():648-655. PubMed ID: 29518611
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma.
    Mann KM; Ward JM; Yew CC; Kovochich A; Dawson DW; Black MA; Brett BT; Sheetz TE; Dupuy AJ; ; Chang DK; Biankin AV; Waddell N; Kassahn KS; Grimmond SM; Rust AG; Adams DJ; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):5934-41. PubMed ID: 22421440
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.